Sinofn Health
Sinofn Health
SINOFN Health Co., Ltd. serves as the premier supplement OEM manufacturing division of the SINOFN Group. Established in 2012, we are a national high-tech enterprise backed by the Chinese Academy of Sciences. We redefine the “Custom Private Label Tablets” market by fusing clinical-grade pharmaceutical technology with consumer health trends.
Our mandate is simple: To provide manufacturers and distributors with scalable, science-backed solutions that prioritize bioavailability, stability, and therapeutic efficacy. Operating from Shanghai, we function as the gateway for global partners requiring high-precision nutraceutical development.
The global nutraceutical market is witnessing a fundamental shift towards personalization and functional efficacy. Modern consumers are no longer satisfied with generic multivitamins; they demand targeted solutions for cognitive health, metabolic regulation, and performance optimization. SINOFN positions itself at the forefront of this evolution by offering:
Led by Dr. Tan Shengjie (Peking University), our focus is on metabolic disorder formulations and the translation of clinical nutrition research into consumer-accessible formats.
Dr. Zhang Ying (Chinese Academy of Sciences) directs our research into delivery systems, specifically improving the delivery of fragile bioactive compounds.
Hans van Dijk, our Dutch Chief Engineer, brings EU regulatory expertise and industrialization proficiency, ensuring our pilot-scale concepts scale seamlessly to mass production.
SINOFN operates state-of-the-art facilities in China, serving global markets including North America, Europe, and Asia. We provide localized regulatory support for international distribution.
Yes. Our R&D center specializes in pilot-scale prototyping. We assist clients in navigating formula feasibility, ingredient stability testing, and dissolution validation before full-scale production runs.
We provide tailored scopes. From small-batch pilot projects for D2C brands to high-volume manufacturing for large multinational health corporations, our lines are modular and scalable.
We prioritize intellectual property with over 36 patents. Our quality management system (ISO9001, ISO22000, HACCP, HALAL) ensures every batch of tablets meets stringent safety and potency standards.
